» Articles » PMID: 27145721

The Fanconi Anaemia Pathway: New Players and New Functions

Overview
Date 2016 May 6
PMID 27145721
Citations 385
Authors
Affiliations
Soon will be listed here.
Abstract

The Fanconi anaemia pathway repairs DNA interstrand crosslinks (ICLs) in the genome. Our understanding of this complex pathway is still evolving, as new components continue to be identified and new biochemical systems are used to elucidate the molecular steps of repair. The Fanconi anaemia pathway uses components of other known DNA repair processes to achieve proper repair of ICLs. Moreover, Fanconi anaemia proteins have functions in genome maintenance beyond their canonical roles of repairing ICLs. Such functions include the stabilization of replication forks and the regulation of cytokinesis. Thus, Fanconi anaemia proteins are emerging as master regulators of genomic integrity that coordinate several repair processes. Here, we summarize our current understanding of the functions of the Fanconi anaemia pathway in ICL repair, together with an overview of its connections with other repair pathways and its emerging roles in genome maintenance.

Citing Articles

Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer.

Rouault C, Bansard L, Martinez-Balsalobre E, Bonnet C, Wicinski J, Lin S Nat Commun. 2025; 16(1):2159.

PMID: 40038300 PMC: 11880418. DOI: 10.1038/s41467-025-57476-4.


The Development of ATM Inhibitors in Cancer Therapy.

Ampolini E, Jimenez-Sainz J, Long D Target Oncol. 2025; .

PMID: 40024979 DOI: 10.1007/s11523-025-01136-6.


Unveiling causal immune cell-gene associations in multiple myeloma: insights from systematic reviews and Mendelian randomization analyses.

Zhang H, Zhang L, Lian J, Kou Z, Zhu Y, Ma L Front Med (Lausanne). 2025; 12:1456732.

PMID: 39911859 PMC: 11794323. DOI: 10.3389/fmed.2025.1456732.


REV7: a small but mighty regulator of genome maintenance and cancer development.

Maggs L, McVey M Front Oncol. 2025; 14:1516165.

PMID: 39839778 PMC: 11747621. DOI: 10.3389/fonc.2024.1516165.


Inhibition of DEK restores hematopoietic stem cell function in Fanconi anemia.

Chen Z, Wu F, Li Y, Li L, Lei Y, Gao S J Exp Med. 2025; 222(3.

PMID: 39836085 PMC: 11748990. DOI: 10.1084/jem.20241248.


References
1.
Klein Douwel D, Boonen R, Long D, Szypowska A, Raschle M, Walter J . XPF-ERCC1 acts in Unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4. Mol Cell. 2014; 54(3):460-71. PMC: 5067070. DOI: 10.1016/j.molcel.2014.03.015. View

2.
Wojtaszek J, Lee C, DSouza S, Minesinger B, Kim H, DAndrea A . Structural basis of Rev1-mediated assembly of a quaternary vertebrate translesion polymerase complex consisting of Rev1, heterodimeric polymerase (Pol) ζ, and Pol κ. J Biol Chem. 2012; 287(40):33836-46. PMC: 3460478. DOI: 10.1074/jbc.M112.394841. View

3.
Kelland L . The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007; 7(8):573-84. DOI: 10.1038/nrc2167. View

4.
Kim J, Parmar K, Huang M, Weinstock D, Ruit C, Kutok J . Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. Dev Cell. 2009; 16(2):314-20. PMC: 3134285. DOI: 10.1016/j.devcel.2009.01.001. View

5.
Nijman S, Huang T, Dirac A, Brummelkamp T, Kerkhoven R, DAndrea A . The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell. 2005; 17(3):331-9. DOI: 10.1016/j.molcel.2005.01.008. View